New Nomogram Predicts Roxadustat Treatment Failure in Anemic PD Patients

A retrospective analysis of 204 anemic PD patients from 2019 to 2023 was used to construct a predictive nomogram of Roxadustat success. Duration of PD, serum transferrin, cardiovascular comorbidities and stains were significant predictors. The nomogram was more predictive at 12 months than at 6 months.

Read the abstract » | (added 2024-04-12)

Tags: Roxadustat, HIF inhibitor, Treatment Failure, Anemia, PD